Hsiao Jane PH D's Form 4 filing
Opko Health, Inc. (OPK) · filed Nov 13, 2023
- Accession no.
- 0001209191-23-054918
- Filed
- Nov 13, 2023
- Trade date
- Nov 10, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $126.7K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hsiao Jane PH DCIK 0001188834 | Director, Officer (Vice Chairman & CTO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2023 | Common Stock | PPurchaseAcquired | +34,058 | $1.26 | +$42,913.08 | 27,633,928 | Direct | |
| Nov 10, 2023 | Common Stock | PPurchaseAcquired | +65,942 | $1.27 | +$83,746.34 | 27,699,870 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.